More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- PMID: 34373540
- PMCID: PMC8352980
- DOI: 10.1038/s41598-021-95565-8
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Abstract
COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. This systematic review and meta-analysis aims to identify studies assessing the long-term effects of COVID-19. LitCOVID and Embase were searched to identify articles with original data published before the 1st of January 2021, with a minimum of 100 patients. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. PRISMA guidelines were followed. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included (age 17-87 years). The included studies defined long-COVID as ranging from 14 to 110 days post-viral infection. It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). Multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.
© 2021. The Author(s).
Conflict of interest statement
The authors are solely responsible for all content, and funders played no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript. S.L.L. is an employee of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. The remaining authors have no competing interests to declare.
Figures


Update of
-
More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.medRxiv [Preprint]. 2021 Jan 30:2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617. medRxiv. 2021. Update in: Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8. PMID: 33532785 Free PMC article. Updated. Preprint.
-
More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis.Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1. Res Sq. 2021. Update in: Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8. PMID: 33688642 Free PMC article. Updated. Preprint.
Comment in
-
80% of patients with COVID-19 have ≥1 long-term effect at 14 to 110 d after initial symptoms.Ann Intern Med. 2022 Jan;175(1):JC10. doi: 10.7326/J21-0007. Epub 2022 Jan 4. Ann Intern Med. 2022. PMID: 34978852
Similar articles
-
More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis.Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1. Res Sq. 2021. Update in: Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8. PMID: 33688642 Free PMC article. Updated. Preprint.
-
More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.medRxiv [Preprint]. 2021 Jan 30:2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617. medRxiv. 2021. Update in: Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8. PMID: 33532785 Free PMC article. Updated. Preprint.
-
Long-COVID in children and adolescents: a systematic review and meta-analyses.Sci Rep. 2022 Jun 23;12(1):9950. doi: 10.1038/s41598-022-13495-5. Sci Rep. 2022. PMID: 35739136 Free PMC article.
-
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.Cephalalgia. 2021 Nov;41(13):1332-1341. doi: 10.1177/03331024211020404. Epub 2021 Jun 16. Cephalalgia. 2021. PMID: 34134526 Free PMC article.
-
Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.Cureus. 2022 Sep 28;14(9):e29694. doi: 10.7759/cureus.29694. eCollection 2022 Sep. Cureus. 2022. PMID: 36321004 Free PMC article. Review.
Cited by
-
Covid Induced Telogen Effluvium (CITE): An Insight.Indian Dermatol Online J. 2022 Jun 24;13(4):445-448. doi: 10.4103/idoj.idoj_139_22. eCollection 2022 Jul-Aug. Indian Dermatol Online J. 2022. PMID: 36262583 Free PMC article. Review.
-
Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients.Neurol Ther. 2022 Dec;11(4):1637-1657. doi: 10.1007/s40120-022-00395-z. Epub 2022 Aug 26. Neurol Ther. 2022. PMID: 36028604 Free PMC article.
-
National long COVID impact and risk factors.Public Health. 2022 Dec;213:177-180. doi: 10.1016/j.puhe.2022.09.021. Epub 2022 Nov 23. Public Health. 2022. PMID: 36434908 Free PMC article.
-
Neurocognitive and Neuropsychiatric Sequelae in Long COVID-19 Infection.Brain Sci. 2024 Jun 14;14(6):604. doi: 10.3390/brainsci14060604. Brain Sci. 2024. PMID: 38928604 Free PMC article.
-
Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: A retrospective case-control study.Front Med (Lausanne). 2022 Oct 6;9:962653. doi: 10.3389/fmed.2022.962653. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36275814 Free PMC article.
References
-
- Ritchie, H., Ortiz-Ospina, E., Beltekian, D., Mathieu, E., Hasell, J., Macdonald, B., Giattino, C., Appel, C., Rodés-Guirao, L., & Roser, M. Coronavirus Pandemic (COVID-19). (2021).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous